|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Advancis Pharmaceutical Corp., of Germantown, Md., said the FDA approved 333-mg and 750-mg capsules of the antibiotic Keflex (cephalexin capsules). Advancis had submitted a supplemental new drug application for the two new strengths. The company expects to begin marketing the new strengths nationwide with a targeted sales force of about 75 representatives beginning in July.
o Affectis Pharmaceuticals AG, of Munich, Germany, identified a gene called P2RX7 that is associated with bipolar affective disorders. The gene encodes for a receptor protein, the P2X7 receptor, suggesting that it could constitute a promising target in bipolar disorders such as mania and ...
Related newspaper, magazine, and journal articles:
|
|
Article: 2 locals named to stem cell research panel: UC ...
San Diego Business Journal;
December 20, 2004 ;
700+ words
...The embryonic stem cell research committee ... will be spent on stem cell research. The money ... Neurosciences at UC San Diego and director of its ... executive officer of San Diego-based closely held ... the pulse for the stem cell work, will find ...
|
|